Impact of Ravulizumab on Patient Outcomes and Quality of Life in Generalized Myasthenia Gravis
{{output}}
Myasthenia gravis (MG) is an autoimmune ion channel disorder in which antibodies to different end-plate antigens impair neuromuscular transmission, ultimately leading to muscle weakness and fatigability. In about 85% of patients with MG, autoantibodies against... ...